Potential signaling pathways, biomarkers, natural drugs, and chronic myeloid leukemia therapeutics.

Front Pharmacol · 2025 · PMC12598037 · PMID 41221040

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

almost insignificantno p-value reported

The current therapeutic goals include producing molecular responses profound enough to make the risks of BC transformation almost insignificant and increasing the long-term rates of treatment-free remission.

also in 189 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.